Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking and Finance Review - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Finance > AstraZeneca shares down 3% after rating cut, UK investment pause
    Finance

    AstraZeneca shares down 3% after rating cut, UK investment pause

    Published by Global Banking and Finance Review

    Posted on September 15, 2025

    2 min read

    Last updated: January 21, 2026

    AstraZeneca shares down 3% after rating cut, UK investment pause - Finance news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:recommendationsvaluationsfinancial markets

    Quick Summary

    AstraZeneca shares dropped 3.4% due to a rating cut by Handelsbanken and a halt in a major UK investment, impacting the stock's performance.

    Table of Contents

    • Impact of Rating Cut on AstraZeneca
    • Stock Performance
    • Company Response
    • Investment Plans

    AstraZeneca Shares Drop 3% Following Rating Downgrade and Investment Halt

    Impact of Rating Cut on AstraZeneca

    By Maggie Fick and Danilo Masoni

    Stock Performance

    LONDON (Reuters) -AstraZeneca shares fell as much as 3.4% on Monday, their steepest drop since May, after Handelsbanken cut its rating on the drugmaker and Reuters reported the company had paused a major investment in its home market.

    Company Response

    The Anglo-Swedish pharmaceutical group's stock underperformed the broader European healthcare index, which was down less than 1% at 11 GMT. Handelsbanken lowered its recommendation on AstraZeneca to "hold" from "buy", citing what it sees as an overly optimistic target of $80 billion in total revenue by 2030.

    Investment Plans

    Britain's biggest listed company became the latest drugmaker to pull back on its business in the country after it paused a planned 200 million pound ($272.12 million) investment in its Cambridge research centre, a spokesperson told Reuters late on Friday. The move comes as a blow to Prime Minister Keir Starmer's government ahead of U.S. President Donald Trump's state visit to Britain this week.

    Shares were down 2.7% at 1100 GMT.

    AstraZeneca, which has a robust drug pipeline of blockbuster cancer medicines, did not immediately respond to a request for comment.

    ($1 = 0.7350 pounds)

    (Reporting by Maggie Fick and Danilo Masoni, Editing by Louise Heavens)

    Key Takeaways

    • •AstraZeneca shares fell 3.4% after a rating downgrade.
    • •Handelsbanken changed its rating from 'buy' to 'hold'.
    • •AstraZeneca paused a £200 million investment in Cambridge.
    • •The stock underperformed the European healthcare index.
    • •The investment pause is a setback for the UK government.

    Frequently Asked Questions about AstraZeneca shares down 3% after rating cut, UK investment pause

    1What caused AstraZeneca's shares to drop?

    AstraZeneca shares fell as much as 3.4% after Handelsbanken cut its rating on the drugmaker.

    2How did AstraZeneca's stock perform compared to the healthcare index?

    AstraZeneca's stock underperformed the broader European healthcare index, which was down less than 1%.

    3What investment decision did AstraZeneca recently make?

    AstraZeneca paused a planned 200 million pound investment in its Cambridge research facility.

    More from Finance

    Explore more articles in the Finance category

    Image for EU proposals set to limit EV sales from 2035, says campaign group
    EU proposals set to limit EV sales from 2035, says campaign group
    Image for Metals, crude oil dive in broad commodities market tumble
    Metals, crude oil dive in broad commodities market tumble
    Image for Trading Day: Solid data over hard assets
    Trading Day: Solid data over hard assets
    Image for Exclusive-OpenAI is unsatisfied with some Nvidia chips and looking for alternatives, sources say
    Exclusive-OpenAI is unsatisfied with some Nvidia chips and looking for alternatives, sources say
    Image for Crypto market volatility triggers $2.5 billion in bitcoin liquidations
    Crypto market volatility triggers $2.5 billion in bitcoin liquidations
    Image for Germany's ProSiebenSat.1 Media reports lower revenue for 2025
    Germany's ProSiebenSat.1 Media reports lower revenue for 2025
    Image for Germany's BayWa in talks with financiers and shareholders on possible changes to restructuring process
    Germany's BayWa in talks with financiers and shareholders on possible changes to restructuring process
    Image for Swiss National Bank Chairman says current situation not easy for policy
    Swiss National Bank Chairman says current situation not easy for policy
    Image for Recycling body opposes EU scrap aluminium export curbs
    Recycling body opposes EU scrap aluminium export curbs
    Image for Czech leader urges EU to overhaul carbon trading schemes to curb energy costs
    Czech leader urges EU to overhaul carbon trading schemes to curb energy costs
    Image for Italy new car sales up by 6.2% year-on-year in January
    Italy new car sales up by 6.2% year-on-year in January
    Image for Telia, Lyse to combine Norwegian mobile radio networks to save costs
    Telia, Lyse to combine Norwegian mobile radio networks to save costs
    View All Finance Posts
    Previous Finance PostFreed Belarusian opposition politician who refused deportation is back in prison, report says
    Next Finance PostSwedish government to hike military spending to 2.8% of GDP in 2026